Nanostring appoints todd garland as chief commercial officer

Seattle--(business wire)--nanostring technologies, inc. (nasdaq:nstg), a provider of life science tools for discovery and translational research, today announced that todd garland has been appointed chief commercial officer, effective august 28, 2023. mr. garland is a senior executive with more than 25 years of experience in healthcare and life sciences technologies that serve customers in the discovery, translational and clinical markets. most recently mr. garland served as chief commercial of.
NSTG Ratings Summary
NSTG Quant Ranking